Atovaquone-Proguanil: A Promising Therapy for Persistent Relapsing Babesiosis
We report a challenging case of persistent relapsing babesiosis in an immunocompromised host that was successfully managed with atovaquone-proguanil (Malarone). Malignant B-cell transformation and immunosuppressants, such as rituximab, deplete normal B-cells which normally produce antibodies to comb...
Saved in:
| Main Authors: | Mahum Shahid, Brendan Wechsler, Vinod Parameswaran, Mark Anthony Diaz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Case Reports in Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/2024/7168928 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atovaquone-proguanil and reduced digestive cancer risk: a Toxoplasma gondii connection
by: Ariel Israel, et al.
Published: (2025-12-01) -
Travellers’ adherence to atovaquone/proguanil malaria chemoprophylaxis after return from endemic areas
by: Jenny Lea Schnyder, et al.
Published: (2025-03-01) -
Treatment of avian malaria in captive African penguins (Spheniscus demersus) by the combination of atovaquone and proguanil hydrochloride
by: Rossella Samarelli, et al.
Published: (2025-12-01) -
Efficacy of azithromycin combined with compounded atovaquone in treating babesiosis in giant pandas
by: Rui Ma, et al.
Published: (2024-12-01) -
BABESIOSIS IN HUMANS
by: Zornitsa Traykova
Published: (2025-01-01)